...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
【24h】

The importance of integrin-linked kinase in the regulation of bladder cancer invasion.

机译:整联蛋白连接的激酶在调节膀胱癌侵袭中的重要性。

获取原文
获取原文并翻译 | 示例

摘要

It is important to understand the molecular mechanisms of bladder cancer progression not only to prevent cancer progression but also to detect new therapeutic targets against advanced bladder cancer. The integrin-linked kinase (ILK) is a major signaling integrator in mammalian cells and plays an important role in epithelial-mesenchymal transition (EMT) of human cancers, but its mechanisms are not completely understood. In this study, we investigated the importance and mechanisms of ILK in bladder cancer progression. When the expression of ILK in bladder cancer cell lines and N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced murine bladder cancer was evaluated, ILK has a tendency to be overexpressed in invasive cell lines and invasive BBN-induced murine bladder cancer. Overexpression of ILK in 253J bladder cancer cells suppressed E-cadherin expression, resulting in the promotion of cell invasion. Conversely, ILK knockdown by siRNA suppresses cell invasion in invasive bladder cancer cells through the regulation of E-cadherin or matrix metalloprotease 9 (MMP-9). To regulate E-cadherin expression, our results showed that the glycogen synthase kinase 3beta (GSK3beta)-Zeb1 pathway may play an important role downstream of ILK. Finally, the results of a human bladder tissue microarray (TMA) showed that ILK expression correlates with the invasiveness of human bladder cancer. Our study suggests that ILK is overexpressed in invasive bladder cancer and plays an important role in the EMT of bladder cancer via the control of E-cadherin and MMP-9 expression. ILK may be a new molecular target to suppress tumor progression in advanced and high-risk bladder cancer patients.
机译:重要的是要了解膀胱癌进展的分子机制,不仅可以预防癌症进展,还可以检测出针对晚期膀胱癌的新治疗靶标。整联蛋白连接的激酶(ILK)是哺乳动物细胞中的主要信号整合者,在人类癌症的上皮-间质转化(EMT)中起着重要作用,但其机理尚不完全清楚。在这项研究中,我们调查了ILK在膀胱癌进展中的重要性和机制。当评估ILK在膀胱癌细胞系和N-丁基-N-(4-羟丁基)亚硝胺(BBN)诱导的鼠类膀胱癌中的表达时,ILK有在浸润性细胞系和BBN诱导的浸润性细胞中过度表达的趋势。鼠膀胱癌。 ILK在253J膀胱癌细胞中的过度表达抑制E-钙粘蛋白的表达,从而促进细胞侵袭。相反,通过调节E-钙粘蛋白或基质金属蛋白酶9(MMP-9),siRNA抑制ILK可以抑制浸润性膀胱癌细胞的侵袭。为了调节E-钙黏着蛋白的表达,我们的结果表明,糖原合酶激酶3β(GSK3beta)-Zeb1途径可能在ILK下游发挥重要作用。最后,人类膀胱组织微阵列(TMA)的结果表明,ILK表达与人类膀胱癌的浸润性相关。我们的研究表明,ILK在浸润性膀胱癌中过表达,并通过控制E-钙黏着蛋白和MMP-9表达在膀胱癌的EMT中发挥重要作用。 ILK可能是抑制晚期和高危膀胱癌患者肿瘤进展的新分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号